These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


PUBMED FOR HANDHELDS

Journal Abstract Search


218 related items for PubMed ID: 11343205

  • 1. Frequency and phenotyping of human immunodeficiency virus (HIV)-specific CD8+ T cells in HIV-infected children, using major histocompatibility complex class I peptide tetramers.
    Scott-Algara D, Buseyne F, Blanche S, Rouzioux C, Jouanne C, Romagné F, Rivière Y.
    J Infect Dis; 2001 Jun 01; 183(11):1565-73. PubMed ID: 11343205
    [Abstract] [Full Text] [Related]

  • 2. Frequency of class I HLA-restricted anti-HIV CD8+ T cells in individuals receiving highly active antiretroviral therapy (HAART).
    Gray CM, Lawrence J, Schapiro JM, Altman JD, Winters MA, Crompton M, Loi M, Kundu SK, Davis MM, Merigan TC.
    J Immunol; 1999 Feb 01; 162(3):1780-8. PubMed ID: 9973442
    [Abstract] [Full Text] [Related]

  • 3. Alterations in T cell phenotype and human immunodeficiency virus type 1-specific cytotoxicity after potent antiretroviral therapy.
    Seth A, Markee J, Hoering A, Sevin A, Sabath DE, Schmitz JE, Kuroda MJ, Lifton MA, Hirsch MS, Collier AC, Letvin NL, McElrath MJ.
    J Infect Dis; 2001 Mar 01; 183(5):722-9. PubMed ID: 11181148
    [Abstract] [Full Text] [Related]

  • 4. Competition of peptide-MHC class I tetrameric complexes with anti-CD3 provides evidence for specificity of peptide binding to the TCR complex.
    Hoffmann TK, Donnenberg VS, Friebe-Hoffmann U, Meyer EM, Rinaldo CR, DeLeo AB, Whiteside TL, Donnenberg AD.
    Cytometry; 2000 Dec 01; 41(4):321-8. PubMed ID: 11084618
    [Abstract] [Full Text] [Related]

  • 5. Circulating HIV-specific CD8+ cytotoxic T cells express CD38 and HLA-DR antigens.
    Ho HN, Hultin LE, Mitsuyasu RT, Matud JL, Hausner MA, Bockstoce D, Chou CC, O'Rourke S, Taylor JM, Giorgi JV.
    J Immunol; 1993 Apr 01; 150(7):3070-9. PubMed ID: 8454874
    [Abstract] [Full Text] [Related]

  • 6. Limited long-term naive CD4+ T cell reconstitution in patients experiencing viral load rebounds during HAART.
    Choremi-Papadopoulou H, Tsalimalma K, Dafni U, Dimitracopoulou A, Kordossis T.
    J Med Virol; 2004 Jun 01; 73(2):235-43. PubMed ID: 15122798
    [Abstract] [Full Text] [Related]

  • 7. Comparison of CD8(+) T-cell subsets in HIV-infected rapid progressor children versus non--rapid progressor children.
    Paul ME, Shearer WT, Kozinetz CA, Lewis DE.
    J Allergy Clin Immunol; 2001 Aug 01; 108(2):258-64. PubMed ID: 11496243
    [Abstract] [Full Text] [Related]

  • 8. HIV-1-infected children on HAART: immunologic features of three different levels of viral suppression.
    Zaccarelli-Filho CA, Ono E, Machado DM, Brunialti M, Succi RC, Salomão R, Kallás EG, de Moraes-Pinto MI.
    Cytometry B Clin Cytom; 2007 Jan 15; 72(1):14-21. PubMed ID: 17041945
    [Abstract] [Full Text] [Related]

  • 9. CD8+ T cell responses to human immunodeficiency viruses type 2 (HIV-2) and type 1 (HIV-1) gag proteins are distinguishable by magnitude and breadth but not cellular phenotype.
    Gillespie GM, Pinheiro S, Sayeid-Al-Jamee M, Alabi A, Kaye S, Sabally S, Sarge-Njie R, Njai H, Joof K, Jaye A, Whittle H, Rowland-Jones S, Dorrell L.
    Eur J Immunol; 2005 May 15; 35(5):1445-53. PubMed ID: 15832290
    [Abstract] [Full Text] [Related]

  • 10. Poor recognition of HIV-1 Nef protein by CD8 T cells from HIV-1-infected children: impact of age.
    Buseyne F, Scott-Algara D, Corre B, Porrot F, Monchatre E, Bellal N, Burgard M, Rouzioux C, Blanche S, Rivière Y.
    Virology; 2006 Oct 25; 354(2):271-9. PubMed ID: 16904156
    [Abstract] [Full Text] [Related]

  • 11. Combination antiretroviral therapy results in a rapid increase in T cell receptor variable region beta repertoire diversity within CD45RA CD8 T cells in human immunodeficiency virus-infected children.
    Kou ZC, Puhr JS, Wu SS, Goodenow MM, Sleasman JW.
    J Infect Dis; 2003 Feb 01; 187(3):385-97. PubMed ID: 12552422
    [Abstract] [Full Text] [Related]

  • 12. The frequency of HIV-specific interferon- gamma -producing CD8 T cells is associated with both age and level of antigenic stimulation in HIV-1-infected children.
    Buseyne F, Scott-Algara D, Bellal N, Burgard M, Rouzioux C, Blanche S, Riviere Y.
    J Infect Dis; 2005 Nov 15; 192(10):1781-6. PubMed ID: 16235177
    [Abstract] [Full Text] [Related]

  • 13. CD8+CD45RA+CD27-CD28-T-cell subset in PBL of cervical cancer patients representing CD8+T-cells being able to recognize cervical cancer associated antigens provided by HPV 16 E7.
    Pilch H, Hoehn H, Schmidt M, Steiner E, Tanner B, Seufert R, Maeurer M.
    Zentralbl Gynakol; 2002 Nov 15; 124(8-9):406-12. PubMed ID: 12655469
    [Abstract] [Full Text] [Related]

  • 14. Improvement in immune parameters and human immunodeficiency virus-1 viral response in individuals treated with 16alpha-bromoepiandrosterone (HE2000).
    Reading C, Dowding C, Schramm B, Garsd A, Onizuka-Handa N, Stickney D, Frincke J.
    Clin Microbiol Infect; 2006 Nov 15; 12(11):1082-8. PubMed ID: 17002607
    [Abstract] [Full Text] [Related]

  • 15. Dominant influence of HLA-B in mediating the potential co-evolution of HIV and HLA.
    Kiepiela P, Leslie AJ, Honeyborne I, Ramduth D, Thobakgale C, Chetty S, Rathnavalu P, Moore C, Pfafferott KJ, Hilton L, Zimbwa P, Moore S, Allen T, Brander C, Addo MM, Altfeld M, James I, Mallal S, Bunce M, Barber LD, Szinger J, Day C, Klenerman P, Mullins J, Korber B, Coovadia HM, Walker BD, Goulder PJ.
    Nature; 2004 Dec 09; 432(7018):769-75. PubMed ID: 15592417
    [Abstract] [Full Text] [Related]

  • 16. Activated peripheral CD8 lymphocytes express CD4 in vivo and are targets for infection by human immunodeficiency virus type 1.
    Imlach S, McBreen S, Shirafuji T, Leen C, Bell JE, Simmonds P.
    J Virol; 2001 Dec 09; 75(23):11555-64. PubMed ID: 11689637
    [Abstract] [Full Text] [Related]

  • 17. Changes in the composition of circulating CD8+ T cell subsets during acute epstein-barr and human immunodeficiency virus infections in humans.
    Roos MT, van Lier RA, Hamann D, Knol GJ, Verhoofstad I, van Baarle D, Miedema F, Schellekens PT.
    J Infect Dis; 2000 Aug 09; 182(2):451-8. PubMed ID: 10915075
    [Abstract] [Full Text] [Related]

  • 18. Persistant immunodominant anti-gag SLYNTVATL responses in HIV-patients with up to 7 years of HAART.
    Zidovec Lepej S, Kosor E, Gagro A, Vince A, Remenar A, Poljak M.
    Coll Antropol; 2006 Dec 09; 30 Suppl 2():33-8. PubMed ID: 17508471
    [Abstract] [Full Text] [Related]

  • 19. Visual demonstration of hepatitis C virus-specific memory CD8(+) T-cell expansion in patients with acute hepatitis C.
    Sobao Y, Tomiyama H, Nakamura S, Sekihara H, Tanaka K, Takiguchi M.
    Hepatology; 2001 Jan 09; 33(1):287-94. PubMed ID: 11124847
    [Abstract] [Full Text] [Related]

  • 20. High responsiveness of HLA-B57-restricted Gag-specific CD8+ T cells in vitro may contribute to the protective effect of HLA-B57 in HIV-infection.
    Jansen CA, Kostense S, Vandenberghe K, Nanlohy NM, De Cuyper IM, Piriou E, Manting EH, Miedema F, van Baarle D.
    Eur J Immunol; 2005 Jan 09; 35(1):150-8. PubMed ID: 15593302
    [Abstract] [Full Text] [Related]


    Page: [Next] [New Search]
    of 11.